Srini Akkaraju is a Managing Director and concentrates on biopharmaceuticals investments. Srini joined New Leaf in January 2009. Prior to joining New Leaf, Srini was a co-founder and Managing Director at Panorama Capital. Before forming Panorama, Srini served as Partner of J.P. Morgan Partners, where he was responsible for leading venture investing in biotech companies. Earlier, Srini held business and corporate development positions at Genentech. During his tenure at Genentech, Srini was responsible for worldwide partnering activities, in-licensing of therapeutics and out-licensing of development projects. In addition, he also was a founding member of BioStreet, an online marketplace for biotech opportunities.

Srini is the author of a number of peer-reviewed articles, including ones published in Science and Nature. He received B.A. degrees in both Biochemistry and Computer Science from Rice University and M.D. and Ph.D. degrees in Immunology from Stanford University School of Medicine.